In Vitro & Ex Vivo Capabilities
Our in vitro and ex vivo capabilities are broad and provide a translational platform for the screening and testing of candidate compounds and target pathways.
Projects can be tailored to client needs, conducted using cells and tissues from healthy and/or diseased sheep, and may include cellular, biochemical and molecular analyses. Allergenix has the expertise as well as access to world-class facilities and services through their partnerships with Monash University and Federation University to enable these studies.
1. Isolated primary cells
- immune cells – blood/lymph node/BAL macrophages, lymphocytes, dendritic cells
- airway cells – epithelial cells, fibroblasts, airway smooth muscle
- monolayers, cell co-cultures
2. Tissue explants
- endobronchial biopsy samples
- tissue explants; tracheal, bronchial
3. Precision-cut lung slices (PCLS)
- airway contractility
- active/passive treatments
Measurements/biomarkers: cell and tissue-specific effects
- tissue structure, cell distribution/structure – histology; histochemistry; immunostaining (surface, intracellular, tissue elements); confocal microscopy; electron microscopy
- immune cell/mediator analyses; cellular, biochemical and molecular analyses
- cell phenotype, activation, function – flow cytometry
- proteins, cytokines, biomarker detection – ELISA; Western Blot
- gene expression analysis – real-time RT-PCR; microarray; single cell profiling (Fluidigm system)